Literature DB >> 6953563

Chromosomal, morphological and clinical correlations in blastic crisis of chronic myeloid leukaemia: a study of 69 cases.

G Alimena, B Dallapiccola, R Gastaldi, F Mandelli, L Brandt, F Mitelman, P G Nilsson.   

Abstract

The karyotypic pattern in 69 patients with Ph1-positive chronic myeloid leukaemia (CML) was investigated during the blastic phase (BC) and correlated with survival and certain parameters of potential prognostic significance, including blast morphology, basophilia and thrombocytopenia. There was no difference in median survival in BC between patients with and without aberrations in addition to the Ph1. Nor were there any differences in this respect among patients with the specific aberrations +Ph1, +8, iso(17q), or other abnormalities. There was no correlation between the incidence of thrombocytopenia and any particular karyotypic change. However, the incidence of basophilia was a characteristic feature for patients with an iso(17q). The survival time in BC was considerably longer in patients with a lymphoid morphology of the blastic cells compared to the myeloid varieties, and within the myeloid varieties the survival in BC was longer in patients with granular differentiated blasts than in those with granular atypical blast cells. No obvious correlation was apparent between blast morphology and karyotypic pattern. However, a pattern was discernible regarding survival and certain chromosomal changes within some morphologic groups: in patients with granular differentiated and lymphoid morphology, the median survival in BC was considerably longer when the bone marrow cells had a Ph1 as the sle abnormality compared to patients who had additional aberrations.

Entities:  

Mesh:

Year:  1982        PMID: 6953563     DOI: 10.1111/j.1600-0609.1982.tb00502.x

Source DB:  PubMed          Journal:  Scand J Haematol        ISSN: 0036-553X


  5 in total

1.  Persistence of derivative chromosome 22 after achieving a major molecular response in chronic myeloid leukemia with a cryptic BCR-ABL1 fusion gene.

Authors:  Hiromichi Matsushita; Atsuko Masukawa; Satoshi Arakawa; Yoshiaki Ogawa; Satomi Asai; Miharu Yabe; Kiyoshi Ando; Hayato Miyachi
Journal:  Int J Hematol       Date:  2009-12-10       Impact factor: 2.490

2.  Cytogenetic heterogeneity in blast crisis (BC) of chronic myelogenous leukemia (CML).

Authors:  J Abramson; R S Verma; J Schwartz
Journal:  Blut       Date:  1985-11

3.  Investigations on karyotype evolution in patients with chronic myeloid leukemia (CML).

Authors:  O A Haas; J D Schwarzmeier; E Nacheva; P Fischer; E Paietta
Journal:  Blut       Date:  1984-01

4.  Translocations (4p+; 6q-) and (12q-; Xp+) in blastic phase of a Ph1-positive chronic myeloid leukemia.

Authors:  S Suciu; E Marinca; F Bornuz; M Crisan; L Petrov; E Rădulescu
Journal:  Blut       Date:  1984-10

5.  Prognostic significance of isochromosome 17q in hematologic malignancies.

Authors:  Dorota Koczkodaj; Justyna Muzyka-Kasietczuk; Sylwia Chocholska; Monika Podhorecka
Journal:  Oncotarget       Date:  2021-03-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.